[Nephrolithiasis-induced ESRD: frequency, causes and prevention]
- PMID: 16895699
- DOI: 10.1016/j.nephro.2005.08.001
[Nephrolithiasis-induced ESRD: frequency, causes and prevention]
Abstract
Nephrolithiasis still remains a too frequent - and under-appreciated - cause of end-stage renal disease (ESRD), and this is all the most unfortunate since such an untoward course is now preventable in most cases. Among 1391 patients who started maintenance dialysis at Necker hospital between 1989 and 2000, nephrolithiasis was identified as the cause of ESRD in 45 of them, an overall prevalence of 3.2%. Infection stones accounted for 42.2% of cases, calcium stones for 26.7%, uric acid stones for 17.8% and hereditary diseases for 13.3%. The proportion of nephrolithiasis-associated ESRD declined from 4.7% to 2.2% from the 1989-1991 to the 1998-2000 period, as a result of the decreased incidence of ESRD in patients with infection and calcium nephrolithiasis. Based on our observations and on published reports, it emerges that most cases of nephrolithiasis-associated ESRD were due to sub-optimal management (especially in the case of infection or cystine stones) or to late (or erroneous) etiologic diagnosis, precluding early institution of appropriate therapeutic measures. In particular, several patients with primary hyperoxaluria or 2,8-dihydroxyadeninuria were diagnosed while already on dialysis or after unsuccessful kidney transplantation, due to wrong initial diagnosis. In conclusion, thanks to recent advances in diagnosis and management of stone formers, ESRD should now be prevented in the great majority of patients, at the condition of early etiologic diagnosis based on accurate morphoconstitutional analysis of calculi and metabolic evaluation, and early implementation of appropriate preventive medical treatment.
Similar articles
-
ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.Am J Kidney Dis. 2004 Nov;44(5):799-805. Am J Kidney Dis. 2004. PMID: 15492945
-
[Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].Nephrol Ther. 2008 Jul;4(4):231-55. doi: 10.1016/j.nephro.2007.12.005. Epub 2008 May 22. Nephrol Ther. 2008. PMID: 18499551 Review. French.
-
Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.Nephrol Dial Transplant. 2010 Jun;25(6):1909-15. doi: 10.1093/ndt/gfp711. Epub 2010 Jan 11. Nephrol Dial Transplant. 2010. PMID: 20064951
-
Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.Am J Kidney Dis. 2018 Dec;72(6):790-797. doi: 10.1053/j.ajkd.2018.06.012. Epub 2018 Aug 23. Am J Kidney Dis. 2018. PMID: 30146423 Free PMC article.
-
Evaluation and medical management of kidney stones in children.J Urol. 2014 Nov;192(5):1329-36. doi: 10.1016/j.juro.2014.04.108. Epub 2014 Jun 21. J Urol. 2014. PMID: 24960469 Review.
Cited by
-
EZH2-mediated macrophage-to-myofibroblast transition contributes to calcium oxalate crystal-induced kidney fibrosis.Commun Biol. 2025 Feb 22;8(1):286. doi: 10.1038/s42003-025-07735-3. Commun Biol. 2025. PMID: 39987296 Free PMC article.
-
7,9-Bis(hy-droxy-meth-yl)-7H-purine-2,6,8(1H,3H,9H)trione.Acta Crystallogr Sect E Struct Rep Online. 2011 Jun 1;67(Pt 6):o1458. doi: 10.1107/S1600536811018186. Epub 2011 May 20. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21754831 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical